Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
7.12
-0.11 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
7.27
2.10%
After-hours: Aug 15, 2025, 05:39 PM EDT

Abeona Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 3.5M 1.41M 3M
Cost of Revenue
2.91M 1.6M 450K 38.73M
Gross Profit
-2.91M 1.9M 964K -1.46M
Operating Income
-64.21M -47.13M -45.26M -89.84M
Interest Income
4.25M 2.12M 431K 40K
Pretax Income
-63.73M -54.19M -43.48M -84.94M
Net Income
-63.73M -54.19M -39.7M -84.94M
Selling & General & Admin
29.85M 19M 17.26M 22.8M
Research & Development
34.36M 31.09M 28.96M 34.33M
Other Expenses
-2.91M -1.06M n/a 35.72M
Operating Expenses
61.3M 49.03M 46.22M 92.84M
Interest Expense
4.21M 418K 736K 3.67M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
64.21M 50.63M 52.33M 92.84M
Income Tax Expense
n/a n/a -7.89M n/a
Shares Outstanding (Basic)
41.05M 21.38M 7.86M 3.94M
Shares Outstanding (Diluted)
41.05M 21.38M 7.86M 3.94M
EPS (Basic)
-1.55 -2.53 -5.53 -21.5
EPS (Diluted)
-1.55 -2.53 -5.53 -21.5
EBITDA
-64.21M -50.57M -34.38M -76.8M
EBIT
-67.94M -53.77M -38.96M -81.27M
Depreciation & Amortization
2.91M 3.2M 4.58M 4.46M